Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Gut Particles Drive Inflammation
Health
May 16, 2026 Evan Vega

Tiny Gut Particles May Drive Aging-Related Inflammation and Chronic Disease, Researchers Say

Researchers found that gut-derived exosomes from older animals trigger inflammation and metabolic changes linked to aging and chronic disease.

Read More
30 Minutes High-Intensity Exercise
Health
May 16, 2026 Evan Vega

Just 30 Minutes of High-Intensity Exercise a Week May Deliver Major Health Gains, Scientists Report

Researchers at NTNU found that 30 minutes of weekly high-intensity exercise can greatly improve heart health and reduce risks of premature death and diseases.

Read More
CDC updates hantavirus precautions
Health
May 16, 2026 Evan Vega

CDC updates hantavirus response as U.S. officials warn risk remains low but urge precautions after exposed travelers are monitored

The CDC activated an emergency response in May 2026 after a hantavirus outbreak linked to a cruise ship, urging precautions while monitoring exposed travelers.

Read More
Infants show Alzheimer biomarker
Health
May 16, 2026 Evan Vega

Healthy infants found to have high blood levels of p-tau217, a key Alzheimer’s biomarker, in new JAMA research

A JAMA study found healthy infants have high blood levels of p-tau217, an Alzheimer’s biomarker, indicating a normal role in early development.

Read More
AI mental-health chatbot regulations
Health
May 14, 2026 Evan Vega

AMA urges Congress to impose safety rules on AI mental-health chatbots as clinical risks draw scrutiny

The AMA urged Congress to enact safety regulations for AI mental-health chatbots to address risks like misinformation and privacy breaches.

Read More
FDA HHS policy debates
Health
May 14, 2026 Evan Vega

Health-system and regulatory watchers brace for new FDA and HHS actions as mifepristone, vaccines, and psychedelic medicine dominate policy debate

Federal health officials prepare new FDA and HHS actions in 2024 amid debates on mifepristone, vaccines, and psychedelic medicine policies.

Read More
Tenerife hantavirus public health
Health
May 14, 2026 Evan Vega

Tenerife grapples with hantavirus response as WHO issues follow-up guidance amid local public health monitoring

Tenerife monitors public health after hantavirus outbreak on MV Hondius, with WHO issuing follow-up guidance amid three confirmed deaths.

Read More
GLP-1 drugs reduce breast cancer
Health
May 13, 2026 Evan Vega

Retrospective study links GLP-1 drugs to lower breast cancer mortality and recurrence, but experts question data quality

A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.

Read More
Cruise-linked hantavirus outbreak
Health
May 13, 2026 Evan Vega

Global health officials race to contain multi-country hantavirus spread after deadly cruise-linked outbreak kills three, including Dutch couple

A hantavirus outbreak linked to the MV Hondius cruise ship killed three, including a Dutch couple, prompting global health containment efforts.

Read More
Aggressive Breast Cancer Immunosuppression
Health
May 12, 2026 Evan Vega

Aggressive Breast Cancer Found to Suppress Immune Response Through Newly Identified Mechanism

Researchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.